Recombinant human FVIIa for reducing the need for invasive second‐line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial

Publisher： John Wiley & Sons Inc

E-ISSN： 1538-7836|13|4|520-529

ISSN： 1538-7933

Source： JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol.13, Iss.4, 2015-04, pp. : 520-529

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A randomized, open‐label clinical trial of tasisulam sodium versus paclitaxel as second‐line treatment in patients with metastatic melanoma

By  

CANCER, Vol. 120, Iss. 13, 2014-07 ,pp. : 2016-2024

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapeutic patient education in children with moderate to severe atopic dermatitis: A multicenter randomized controlled trial in China

By  

PEDIATRIC DERMATOLOGY, Vol. 35, Iss. 1, 2018-01 ,pp. : 70-75

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nebulized hypertonic saline in infants hospitalized with moderately severe bronchiolitis due to RSV infection: A multicenter randomized controlled trial

By  

PEDIATRIC PULMONOLOGY, Vol. 53, Iss. 3, 2018-03 ,pp. : 358-365

John Wiley & Sons Inc

Access to resources Recommend Favorite

Immunologic Effects of Omalizumab in Children with Severe Refractory Atopic Dermatitis: A Randomized, Placebo-Controlled Clinical Trial

By  

International Archives of Allergy and Immunology, Vol. 162, Iss. 1, 2013-06 ,pp. : 89-93

Karger

Access to resources Recommend Favorite

Internet-Delivered Disease Management for Recurrent Depression: A Multicenter Randomized Controlled Trial

By  

Psychotherapy and Psychosomatics, Vol. 85, Iss. 2, 2016-0 ,pp. : 91-98

Karger

Access to resources Recommend Favorite